Bioline Rx Ltd (ADR) - BLRX - stock price prediction, stock price target, analyst ratings from 2 analysts

Bioline Rx Ltd (ADR) has a share price target of US$ 20, revenue growth forecast of -94.9%, and profit growth estimate of 66.7% for FY25, based on top 2 analyst calls.